Exosomal non-coding RNAs: a new avenue for treating diabetic foot ulcers
Chen G., Chen G., Lu J., Hu S.
Clinical Trial on Diabetic Foot, Chronic Wound, published in Front Mol Biosci (2025) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Clinical Trial
- Journal
- Front Mol Biosci (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41438998
- PMCID
- PMC12719090
- DOI
- 10.3389/fmolb.2025.1701879
- Citations
- 1
Abstract (original English)
Diabetic foot ulcer (DFU) is a severe complication resulting from diabetes mellitus (DM) that affects approximately 18.6 million individuals annually and has a lifetime incidence of up to 25% among DM patients. These ulcers often precede lower-extremity amputations and are associated with high mortality as well as economic burden that necessitate innovative therapeutic strategies beyond conventional methods. Recent research efforts have highlighted the potential of non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), that regulate gene expression and cellular functions critical for wound healing. Exosomes are the natural carriers of ncRNAs and offer a promising avenue for the treatment of DFU by enhancing the stabilities and bioavailabilities of these molecules. In this review, we explore the substantial potential of ncRNAs in DFU treatment by emphasizing the action mechanisms of ncRNAs, refinement of exosome-based delivery systems, and expansion of clinical trials to translate ncRNA-based therapies into clinical practice. The application of exosomal ncRNAs involves diverse strategies through different mechanisms, although there remain challenges in terms of exosome preparation consistency, functional enhancement, and efficient drug delivery. The future directions in this regard include optimizing isolation techni
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations